B+
Bull case
20%
Probability
Target price
$3.80
Analysis reference price unavailable
Analysis 2026-07-24 · RankAlpha Sentiment Codex
CYH
Community HealthDNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
45%
Probability
Target price
$2.70
Analysis reference price unavailable
Analysis 2026-07-24 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$1.85
Analysis reference price unavailable
Analysis 2026-07-24 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-07-24
Recent news sentiment (30D)
-0.7
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+49.9
Score
AI commentary
Post-earnings news tone is negative: coverage emphasized the guidance reduction, wider adjusted loss and operating headwinds, while Investing.com reported a 12.83% after-hours decline (https://www.investing.com/news/company-news/community-health-q2-2026-slides-volume-gains-offset-by-margin-pressure-93CH-4809594). The price remained near $2.73 by July 24. Analyst revisions and social coverage are unavailable, so missing reaction data is not positive evidence.
RankAlpha Sentiment Codex - 2026-07-24
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-07-27catalystQ2 earnings underperformance and updated FY2026 outlookHigh impact
Q2 net operating revenue was $2.825 billion, adjusted EBITDA was $330 million versus $380 million a year earlier, and adjusted diluted EPS was -$0.19 versus -$0.05. The company issued updated FY2026 guidance of $11.4-$11.6 billion revenue and $1.3-$1.375 billion adjusted EBITDA, citing divestitures, unfavorable payer mix and higher medical specialist fees [#8-K-2026-07-22] [#SEC-8K-2026-07-22].
2026-10-22eventQ3 execution against the reset operating baseHigh impact
The next checkpoint is whether same-store volume gains convert into revenue, margin and cash flow. Q2 same-store admissions rose 1.9% and adjusted admissions 2.9%, but consolidated revenue fell 9.8%, adjusted EBITDA fell 13.2%, and first-half operating cash flow was negative $209 million. Stored earnings-call context highlights uninsured/ACA disenrollment and elective-surgery softness as back-half risks [#SEC-8K-2026-07-22] [#EARNINGS-TRANSCRIPT-2026Q2].
2026-12-31catalystDebt reduction and operating-quality improvementsHigh impact
CYH used divestiture proceeds to repurchase approximately $599 million of secured-note principal. The official release also cites lower contract labor and professional-liability expenses, increased reimbursement rates and improving same-store volumes. Sustained cash generation and leverage improvement could support a rerating, but the thesis remains conditional [#8-K-2026-07-22] [#EARNINGS-TRANSCRIPT-2026Q2].
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-24 • Updated nightlySource: Internal modelMethodology